268 related articles for article (PubMed ID: 29388727)
1. Special AT-rich sequence binding protein 1 is required for maintenance of T cell receptor responsiveness and development of experimental autoimmune encephalomyelitis.
Akiba Y; Kuwabara T; Mukozu T; Mikami T; Kondo M
Microbiol Immunol; 2018 Apr; 62(4):255-268. PubMed ID: 29388727
[TBL] [Abstract][Full Text] [Related]
2. Histamine H₂ receptor signaling × environment interactions determine susceptibility to experimental allergic encephalomyelitis.
Saligrama N; Case LK; Krementsov DN; Teuscher C
FASEB J; 2014 Apr; 28(4):1898-909. PubMed ID: 24371118
[TBL] [Abstract][Full Text] [Related]
3. Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis.
Chang TT; Jabs C; Sobel RA; Kuchroo VK; Sharpe AH
J Exp Med; 1999 Sep; 190(5):733-40. PubMed ID: 10477557
[TBL] [Abstract][Full Text] [Related]
4. Ethanol extract of Glycyrrhizae Radix modulates the responses of antigen-specific splenocytes in experimental autoimmune encephalomyelitis.
Yang EJ; Song IS; Song KS
Phytomedicine; 2019 Feb; 54():56-65. PubMed ID: 30668383
[TBL] [Abstract][Full Text] [Related]
5. TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis.
Chyuan IT; Tsai HF; Wu CS; Sung CC; Hsu PN
Front Immunol; 2018; 9():15. PubMed ID: 29403497
[TBL] [Abstract][Full Text] [Related]
6. Induction of experimental autoimmune encephalomyelitis in the absence of c-Jun N-terminal kinase 2.
Nicolson K; Freland S; Weir C; Delahunt B; Flavell RA; Bäckström BT
Int Immunol; 2002 Aug; 14(8):849-56. PubMed ID: 12147621
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulation By Subchronic Low Dose 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Experimental Autoimmune Encephalomyelitis in the Absence of Pertussis Toxin.
Yang EJ; Stokes JV; Kummari E; Eells J; Kaplan BL
Toxicol Sci; 2016 May; 151(1):35-43. PubMed ID: 26822306
[TBL] [Abstract][Full Text] [Related]
8. Soluble MOG35-55/I-A(b) dimers ameliorate experimental autoimmune encephalomyelitis by reducing encephalitogenic T cells.
Gong Y; Wang Z; Liang Z; Duan H; Ouyang L; Yu Q; Xu Z; Shen G; Weng X; Wu X
PLoS One; 2012; 7(10):e47435. PubMed ID: 23077616
[TBL] [Abstract][Full Text] [Related]
9. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells.
Mendel I; Kerlero de Rosbo N; Ben-Nun A
Eur J Immunol; 1995 Jul; 25(7):1951-9. PubMed ID: 7621871
[TBL] [Abstract][Full Text] [Related]
10. CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis.
Li O; Liu JQ; Zhang H; Zheng P; Liu Y; Bai XF
Scand J Immunol; 2006 Aug; 64(2):117-24. PubMed ID: 16867156
[TBL] [Abstract][Full Text] [Related]
11. Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C theta-deficient mice.
Tan SL; Zhao J; Bi C; Chen XC; Hepburn DL; Wang J; Sedgwick JD; Chintalacharuvu SR; Na S
J Immunol; 2006 Mar; 176(5):2872-9. PubMed ID: 16493044
[TBL] [Abstract][Full Text] [Related]
12. The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein. T cell receptors in inflammatory lesions.
Sobel RA; Kuchroo VK
J Immunol; 1992 Aug; 149(4):1444-51. PubMed ID: 1380045
[TBL] [Abstract][Full Text] [Related]
13. Active Induction of Experimental Autoimmune Encephalomyelitis (EAE) with MOG
Giralt M; Molinero A; Hidalgo J
Methods Mol Biol; 2018; 1791():227-232. PubMed ID: 30006713
[TBL] [Abstract][Full Text] [Related]
14. The PD-1/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma.
Cheng X; Zhao Z; Ventura E; Gran B; Shindler KS; Rostami A
J Neuroimmunol; 2007 Apr; 185(1-2):75-86. PubMed ID: 17320975
[TBL] [Abstract][Full Text] [Related]
15. Innate IFN-γ promotes development of experimental autoimmune encephalomyelitis: a role for NK cells and M1 macrophages.
Dungan LS; McGuinness NC; Boon L; Lynch MA; Mills KH
Eur J Immunol; 2014 Oct; 44(10):2903-17. PubMed ID: 25056715
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical effect of pertussis toxin on the delayed hypersensitivity response to autoantigens in mice.
Yadav R; Bhowmick S; Gorecki P; O'Rourke J; Cone RE
PLoS One; 2010 Aug; 5(8):e11983. PubMed ID: 20700542
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo.
Bedoui S; Miyake S; Lin Y; Miyamoto K; Oki S; Kawamura N; Beck-Sickinger A; von Hörsten S; Yamamura T
J Immunol; 2003 Oct; 171(7):3451-8. PubMed ID: 14500640
[TBL] [Abstract][Full Text] [Related]
18. A novel protective model against experimental allergic encephalomyelitis in mice expressing a transgenic TCR-specific for myelin oligodendrocyte glycoprotein.
Mendel I; Natarajan K; Ben-Nun A; Shevach EM
J Neuroimmunol; 2004 Apr; 149(1-2):10-21. PubMed ID: 15020060
[TBL] [Abstract][Full Text] [Related]
19. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
Mony JT; Khorooshi R; Owens T
Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
[TBL] [Abstract][Full Text] [Related]
20. EAE mediated by a non-IFN-γ/non-IL-17 pathway.
Kroenke MA; Chensue SW; Segal BM
Eur J Immunol; 2010 Aug; 40(8):2340-8. PubMed ID: 20540117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
